Related articles

Novo Nordisk

Company marketing Wegovy and developing CagriSema; competes with Eli Lilly in the obesity drug market.

• Data Center Opposition Emerges as Key Election Signal for Stocks
• Novo Nordisk introduces oral Wegovy weight-loss pill in Spain
• Three key forces set to shape the U.S. stock market this week
• Energy companies avoid renewed scrutiny over higher profits
• Scientists build an electrically driven molecular motor inspired by Archimedes’ screw
• Wegovy Pill Arrives in French Pharmacies as Obesity Drug Competition Heats Up